Elderly patients are not at increased risk of serious infections when receiving bDMARDs or JAK inhibitors compared to csDMARD treatment. eular e-congress. EULAR E-Congress 2021 - Strangfeld, A; Manger, B; Worsch, M (Ann Rheum Dis, 2021)